Description
BSE announces the upcoming listing and admission to trading of equity shares of Gujarat Kidney and Super Speciality Limited with scrip code 544666.
Summary
BSE has announced that the equity shares of Gujarat Kidney and Super Speciality Limited will be listed and admitted to dealings on the Exchange. The company has been assigned scrip code 544666 and symbol GKSL with ISIN number INE0V0W01025. The exact listing date and security details will be communicated through a separate notice.
Key Points
- Company Name: Gujarat Kidney and Super Speciality Limited
- Scrip Code: 544666
- Trading Symbol: GKSL
- ISIN Number: INE0V0W01025
- Listing status: Approved, date to be announced
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE Limited
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
Trading members of the Exchange are informed to prepare for the upcoming listing of GKSL equity shares. No immediate compliance actions required pending the separate notice with specific listing date and security details.
Important Dates
- Notice Date: December 29, 2025
- Listing Date: To be announced through separate notice
- Security Details Publication: To be announced through separate notice
Impact Assessment
This is a routine new listing announcement with minimal immediate market impact. The listing will add a new healthcare sector company to BSE’s equity segment. Trading members should note the scrip details for future reference. The actual market impact will depend on the company’s size, offering details, and sector positioning, which will be clarified in the subsequent detailed listing notice.
Impact Justification
Standard new listing announcement with limited immediate market impact; specific listing date to be announced separately